Relmada Therapeutics Preferred Securities out of Shareholders Equity (Quarterly) Trends

Relmada Therapeutics, Inc. (RLMD)

3.74 -0.06 (-1.58%) USD | NASDAQ | Jan 16, 16:00

3.745 0.00 (0.00%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for RLMD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
Invivyd, Inc.	--
Arcellx, Inc.	--
Puma Biotechnology, Inc.	--
NovaBay Pharmaceuticals, Inc.	--